In this episode of Rotten Mango, the podcast examines Lindsay Clancy's psychiatric treatment in the months leading up to a tragic event, focusing on testimony from healthcare providers involved in her care. The episode covers the unusually rapid medication changes Lindsay experienced—approximately 35 prescription or dosage adjustments over four months—involving multiple psychiatric drugs including antidepressants, benzodiazepines, and antipsychotics.
The discussion highlights concerns about fragmented care between providers, the debate over whether Lindsay had undiagnosed bipolar disorder, and potential warning signs that may have been missed. Key issues include the lack of coordination between Lindsay's in-person and telehealth prescribers, questions about documentation practices and diagnostic screening, and the significance of symptoms like severe insomnia without fatigue. The episode explores how these factors contributed to a complex case that raises questions about psychiatric prescribing practices and patient safety.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Between September 2022 and January 2023, Lindsay experienced approximately 35 prescription or dosage changes involving 13 different psychiatric drugs over just four months. These included SSRIs, benzodiazepines, antipsychotics, and mood stabilizers, with medications frequently ramped up, decreased, or swapped without noticeable improvement. Lindsay reported feeling "disconnected, out of it, spacey," and the relentless medication switching, especially in November and December, failed to provide meaningful relief.
Lindsay's records show repeated cycling between different benzodiazepines—[restricted term], [restricted term], and [restricted term]—sometimes without confirmed return of unused medication or proper documentation. Nurse practitioner Julie Paul initially intended to taper Lindsay off [restricted term] toward [restricted term], a non-benzodiazepine alternative, but allowed continued [restricted term] use. Later, Rebecca Jelada switched Lindsay to [restricted term] to minimize rebound anxiety. This rapid and overlapping benzodiazepine cycling, carried out without consistent documentation or medication reconciliation, triggered concerns about potentially negligent prescribing and high dependency risk.
Jelada prescribed [restricted term] in late November 2022, initially for sleep and anxiety, later considering it might address possible bipolar symptoms. Despite Lindsay reporting feeling "weighed down and exhausted" with no perceived benefit, her dosage was increased rapidly to as high as 400 mg. Both Lindsay and her husband Patrick stated that [restricted term] initiated her most severe downturn, with increased depressive and intrusive thoughts. Despite their requests to discontinue, the clinical approach oscillated rapidly—one day discontinuing [restricted term], the next day up-titrating it again.
Dr. Tufts's documentation practices came under scrutiny for using checklists instead of detailed clinical notes. One contentious example was an October 2022 note reading "not hyper, pressured speech," which created confusion about whether Lindsay displayed pressured speech or whether Tufts meant to document its absence. Many healthcare professionals criticized this checkbox system as inadequate for capturing nuanced patient presentations, with observers stating this case will serve as a cautionary example for decades regarding the need for thorough, clear documentation.
Jelada is the only provider to openly suspect Lindsay might have bipolar disorder, based on her unusual reaction to 50mg of [restricted term]—remaining awake for 48 hours without feeling tired—and difficulty tolerating other antidepressants. Despite Jelada's concerns, Lindsay and Patrick strongly rejected this diagnosis, with Patrick plainly stating "my wife is not bipolar." Jelada acknowledged their disagreement but felt responsible to forward her clinical observations regardless.
Dr. Tufts never observed or documented manic or hypomanic symptoms, describing Lindsay as presenting with the "opposite" of mania: tiredness, slowed movements, and dysphoria. However, legal observers note that Dr. Tufts' defensive demeanor during proceedings weakened her credibility despite her clear clinical assertions.
After delivering her third child, Callan, Lindsay ran a 5k race just weeks postpartum, exercised intensely at 4 AM, and lost over 15 pounds rapidly—behaviors Jelada was unaware of during treatment but acknowledges would have been significant diagnostic clues. Similarly, after her second child Dawson, Lindsay engaged in excessive exercise and became heavily involved in a multi-level marketing fitness scheme. Legal arguments assert that these postpartum behaviors, if more thoroughly investigated, should have cued clinicians to bipolar disorder risk.
Both Julie Paul and Dr. Tufts prescribed SSRIs to Lindsay without any accompanying mood stabilizer or formal bipolar screening. Jelada and commentators observe that in patients with undiagnosed bipolar disorder, prescribing SSRIs alone can lead to rapid cycling between depressive and manic episodes. The clinicians' willingness to prescribe SSRIs without robust screening or concurrent mood stabilization forms a core element of debate in the case.
Dr. Tufts and Jelada, Lindsay's in-person and telehealth prescribers, never communicated or shared records about Lindsay's care. Both providers depended on Lindsay to self-report what the other was prescribing, raising significant medication safety risks. This fragmentation hid Lindsay's full psychiatric symptom burden and the sheer number of recent medication adjustments—35 changes went largely unrecognized because critical information stayed siloed between providers.
Defense attorney Reddington pressed both providers on why they never sought information from Patrick or Lindsay's mother to gather perspective on her functioning and behaviors. Both providers defended their decision, citing time constraints and absence of glaring red flags. However, Reddington and other observers challenged this, questioning whether the clinical picture was as straightforward as the providers suggested. It emerged on cross-examination that both providers primarily relied on Lindsay's own reports without seeking collateral input, bypassing psychiatric best practices.
Patrick attended at least one appointment with Jelada, where he reported Lindsay's panic symptoms and attributed her deterioration to [restricted term], noting weight loss and suicidal ideation. Patrick also asserted "my wife is not bipolar," directly affecting the information Jelada received and possibly influencing clinical decisions. The degree to which Patrick's opinions shaped prescribing decisions remains contested among commentators and involved parties.
The absence of provider coordination led to divergent clinical philosophies: Dr. Tufts prescribed SSRIs for depression and anxiety while Jelada, suspecting bipolar disorder, initiated [restricted term] for mood stabilization. Had there been communication and collaboration, patterns in Lindsay's medication intolerance and symptom progression might have been recognized earlier, allowing for a more unified and effective diagnosis and treatment regimen.
On November 18th, Lindsay wrote in her journal: "It's like I'm so desperate to get a mental break from taking care of everyone that my mind is trying to make something physically wrong with me... I can't shut it off." Letitia Duke documented Lindsay's intrusive thoughts, suicidal ideation, deep worry for her children, emotional numbness, and sleep difficulties. On December 5th, Lindsay called the Aspire Crisis Support hotline for suicidal thoughts but lacked a specific plan, so she was not triaged for hospitalization—representing a missed opportunity for urgent intervention.
Despite taking [restricted term], Melatonin, and Benadryl, Lindsay was getting only three to four hours of sleep nightly. Crucially, she reported not feeling tired despite profound sleep deprivation, stating "the weird thing is I don't feel tired at all." Jelada recognized that while patients with anxiety or depression-related insomnia are usually exhausted, Lindsay's absence of fatigue despite very little sleep suggested an underlying manic or mixed state. Both providers and coverage emphasized that this indicator—severe insomnia without fatigue—may represent a severe and potentially dangerous underlying mood disorder rather than basic postpartum depression.
Recognizing the seriousness of Lindsay's symptoms, Jelada strongly recommended partial hospitalization, conveying that Lindsay's depression, anxiety, and possible mania warranted more intensive treatment than standard outpatient care. Despite acknowledging the severity of her presentation, neither provider escalated to involuntary hospitalization or emergency intervention after Lindsay declined, citing logistical incompatibility with family responsibilities. This approach raises questions over whether providers were respecting Lindsay's autonomy or inadequately assessing potential risks.
Providers failed to obtain comprehensive information about Lindsay's postpartum experiences and prior psychiatric symptoms. Lindsay had disclosed to Julie that she felt overwhelmed after Dawson's birth—an important detail pointing to possible recurring postpartum mood episodes. The lack of systematic inquiry into Lindsay's prior postpartum mood episodes and medication responses meant opportunities were missed to inform diagnostic and treatment decisions, potentially preventing earlier recognition of her high risk for severe psychiatric reactions.
1-Page Summary
Between September 15, 2022 and January 23, 2023, Lindsay experienced an extraordinarily rapid series of psychiatric medication adjustments. Over roughly four months, there were approximately 35 prescription or dosage changes encompassing 13 different psychiatric drugs. These included SSRIs ([restricted term], [restricted term]), benzodiazepines ([restricted term], [restricted term], [restricted term]), antipsychotics ([restricted term]), antidepressants ([restricted term], [restricted term], [restricted term], [restricted term], [restricted term]), sleep aids ([restricted term]), mood stabilizers/anticonvulsants ([restricted term]), and sedating agents. The clinical approach alternated frequently: some medications were ramped up in dosage, others decreased or swapped out, often without noticeable long-term improvement in Lindsay's condition. Lindsay reported feeling "disconnected, out of it, spacey," and the medicine switching, especially in November and December, became relentless, failing to provide meaningful relief.
Lindsay's records show repeated cycling between different benzodiazepines. Initially prescribed [restricted term], she began experiencing concerns about dependence and self-weaned herself off the medication. Julie Paul, the nurse practitioner, intended to taper Lindsay off [restricted term] and move her toward [restricted term], a non-benzodiazepine anxiety remedy, but allowed the continued use of [restricted term] for severe anxiety. [restricted term], a longer-acting benzodiazepine, was then prescribed to replace [restricted term]. After only two nights on [restricted term], Lindsay requested to stop it, which was approved, but she soon suffered a panic attack and was told to resume [restricted term].
Later, on transfer to Rebecca Jelada, the approach shifted to [restricted term], another benzodiazepine with an even longer half-life. Jelada explained the aim was to minimize rebound anxiety, a phenomenon where anxiety levels spike after the effects of a benzodiazepine wear off. However, this substitution meant that Lindsay was sequentially prescribed [restricted term], [restricted term], and [restricted term]—sometimes without confirmed return of unused medication or documentation ensuring compliance. The process of switching benzodiazepines repeatedly, rather than a structured taper, was criticized as reckless and out-of-line with best practices. Such polypharmacy not only presents a high risk of dependency but also muddy records about actual patient usage.
This rapid and overlapping benzodiazepine cycling, carried out without consistent documentation or medication reconciliation, triggered concern about potentially negligent prescribing rather than sound medical practice. Some viewed it as a response to patient anxiety and distress, while others saw it as failing to monitor for misuse or prevent harm, particularly given the risk of dependency.
Lindsay's first appointment with Rebecca Jelada in late November 2022 led to another major escalation: Jelada prescribed [restricted term] at 25 mg, initially for sleep and anxiety, later considering it might address mood stabilization or untreated bipolar spectrum symptoms. [restricted term], an antipsychotic, was introduced cautiously but the plan rapidly shifted. While Lindsay voiced strong negative reactions—reporting feeling "weighed down and exhausted," with her mind still alert, and with no perceived benefit—her dosage was increased quickly. Jelada described titrating [restricted term] according to manufacturer guidelines for manic symptoms: 100 mg on day one, 200 mg on day two, 300 mg on day three, and 400 mg on day four. [restricted term] was moved from immediate release to extended release, extending its presence in her system from four to twelve hours. Lindsay's dosage escalated to as high as 400 mg despite distress and worsening symptoms, including reports of increased depressive and intrusive thoughts. Both Lindsay and her husband Patrick stated that [restrict ...
Psychiatric Medication Management and Prescribing Practices
Psychiatric nurse Rebecca Jelada is the only provider to openly suspect Lindsay Clancy might have an underlying bipolar disorder, based on significant medication responses and treatment difficulties. Jelada notes Lindsay’s unusual reaction to 50mg of [restricted term], where Lindsay remained awake for 48 hours without feeling tired. Jelada flags this "inactivating response" as highly atypical, suggesting a possible mood disorder like bipolar. Additionally, Lindsay exhibited difficulty tolerating other antidepressants, reinforcing Jelada's suspicion that underlying bipolar disorder could be affecting antidepressant efficacy.
Despite Jelada’s concerns, Lindsay and her husband Patrick strongly reject the bipolar diagnosis. Jelada recounts discussions where Patrick plainly states, "my wife is not bipolar," and Lindsay offers no response. Jelada acknowledges their disagreement but feels responsible to forward her clinical observations regardless.
Other care providers, notably Dr. Tufts, do not observe or document any manic or hypomanic symptoms. Dr. Tufts’ clinical experience with Lindsay points primarily to fatigue and depression, describing Lindsay as presenting with the "opposite" of mania: tiredness, slowed movements, and dysphoria rather than hyperactivity, rapid speech, or euphoria. Dr. Tufts testifies that she never observed mania or manic markers in Lindsay. However, legal observers note that Dr. Tufts' defensive demeanor and tendency to reinterpret her clinical notes during legal proceedings weakened her credibility, despite her clear clinical assertions.
After the birth of her third child, Callan, Lindsay’s behavior drew retrospective suspicion of hypomania. She ran a 5k race just weeks postpartum against the wishes of her husband, exercised intensely at 4 AM—often waking before her children to run three miles, spin for 30 minutes, and complete 30 more minutes of aerobics—and lost over 15 pounds rapidly. Jelada was unaware of these behaviors during her time treating Lindsay but acknowledges they would have been significant diagnostic clues.
Lindsay’s civil suit now argues that competent psychiatric providers should have gathered a thorough post-delivery history. After giving birth to her second child, Dawson, Lindsay again embarked on excessive exercise routines and became heavily involved in a multi-level marketing fitness scheme—purchasing large quantities of inventory and promoting exercise videos online—manifesting signs that could suggest hypomanic episodes.
Legal arguments assert that these ...
Diagnosis Debate: Underlying Bipolar Disorder
The case highlights serious failures in communication and coordination among Lindsay’s telehealth and in-person prescribers, with direct risks to her medication safety and psychiatric care.
Dr. Tufts and Jelada, Lindsay’s in-person and telehealth prescribers, never communicated or shared records about Lindsay’s care. Both providers depended on Lindsay to self-report what the other was prescribing. They each indicated there was no perceived medication overlap, but this assertion was based only on Lindsay's reports rather than coordinated medical records.
This lack of provider communication made it difficult to recognize and address overlapping medications in Lindsay’s regimen, raising significant medication safety risks.
Because of fragmentation in her care, Lindsay’s full psychiatric symptom burden, the seriousness of her condition, and the sheer number (35) of recent medication adjustments went largely unrecognized. Without an integrated view, critical information about her escalating psychiatric symptoms and her complex, unstable medication plan stayed siloed between providers.
During court proceedings, defense attorney Reddington pressed both Tufts and Jelada on why they never sought collateral information from Lindsay's husband, Patrick Clancy, or her mother. Reddington suggested this lack of outreach denied them valuable perspective on Lindsay’s true mental status, as family observations can reveal crucial behavioral data.
Both providers defended their decision, citing time constraints and the absence of glaring red flags in Lindsay’s clinical presentation. They argued that reaching out for additional information from an adult patient's parents is unfeasible unless urgent warning signs are evident, a position some healthcare professionals support. However, Reddington and other observers challenged this, questioning whether the clinical picture was, in fact, as straightforward as the providers suggested.
It emerged on cross-examination that both Jelada and Tufts primarily relied on Lindsay’s own reports and did not seek collateral input, even though psychiatric best practices often recommend gathering outside information for a more accurate assessment.
Patrick Clancy attended at least one appointment with Lindsay and Dr. Jelada, adding a layer of complexity to communication lines in her treatment.
At this appointment, Patrick reported that Lindsay kept waking up with panic symptoms. He linked her downward spiral and deteriorating mental health to the introduction of [restricted term], noting significant weight loss, deepening depression, and suicidal ideation. He observed that Lindsay was negatively affected and seemed to worsen on [restricted term].
During the appointment, Patrick asserted, “my wife is not bipolar,” directly affecting the information Dr. Jelada received and possibly influencing clinical decisions. Although ...
Lack of Coordination and Communication Among Multiple Providers
On November 18th, two days after an emergency room visit, Lindsay wrote in her Tree of Life Journal: "It's like I'm so desperate to get a mental break from taking care of everyone that my mind is trying to make something physically wrong with me. My mind never shuts off. It's constantly thinking of the next thing someone needs. I can't shut it off. I desperately want to go back to work, but now I don't know how to function and it worries me." This entry captures the overwhelming strain of caregiving and declining mental health.
Letitia Duke documented that Lindsay experienced intrusive thoughts, suicidal ideation, deep worry for her children, emotional numbness, sleep difficulties, and ongoing anxiety. On December 5th, Lindsay reported to Letitia that over the weekend she had intrusive thoughts and contacted the Aspire Crisis Support hotline for help. She met a clinician virtually but was informed she did not meet criteria for inpatient treatment due to not having a specific suicide plan.
Despite reporting suicidal thoughts to Aspire Crisis Support on December 5, Lindsay's lack of a concrete plan led providers not to triage her for hospitalization, representing a missed opportunity for more urgent intervention during a crisis.
Despite taking prescribed sedatives such as [restricted term], Melatonin, and even Benadryl, Lindsay communicated to her provider on December 7th that she was getting at best three to four hours of sleep nightly. For example, she wrote, “Last night did not go well at all. I took the [restricted term] and Melatonin and only slept from nine to one. Then around two I got desperate and took 25 milligrams of Benadryl and only slept about one more hour. What can I do? I really need help.” This severe insomnia persisted even while Lindsay had support with childcare and her environment allowed for rest, which differs from typical postpartum sleep problems attributed to infant care.
Crucially, Lindsay reported to providers that she was not feeling tired despite profound sleep deprivation—she stated, “No the weird thing is I don’t feel tired at all.” Her provider, Rebecca Jilada, recognized that while patients with anxiety or depression-related insomnia are usually exhausted, Lindsay’s absence of fatigue despite very little sleep suggested an underlying manic or mixed state. Jilada later described Lindsay’s symptoms as “a mixture of symptoms” or a “mixed state” that is “clinically acute,” noting that in bipolar disorder, patients may go on very little sleep without tiredness. Both providers and coverage by Stephanie Soo emphasized that this indicator—severe insomnia without fatigue—may represent a severe and potentially dangerous underlying mood disorder rather than basic postpartum depression or anxiety.
Recognizing the seriousness of Lindsay's symptoms, Jilada strongly recommended a partial hospitalization program for more comprehensive treatment. She conveyed that Lindsay’s depression, anxiety, and possible mania warranted seeing her in person weekly, and suggested that outpatient therapy and medication might not be sufficient. Julie also encouraged this level of care.
Despite acknowledging the severity of her presentation, neither provider escalated to involuntary hospitalization, emergency department intervention, or crisis services after Lindsay declined the suggested partial hospitalization. Julie documented that Lindsay felt such a program was logistically incompatible with her family responsibilities, and this reason was accepted without further escalation. Stephanie Soo highlights how even when Lindsay’s providers recognized the need for more inte ...
Post-Partum Psychiatric Symptoms and Unrecognized Warning Signs
Download the Shortform Chrome extension for your browser
